Eternygen GmbH - Company Review
Eternygen GmbH - Company ReviewSummary
Eternygen GmbH (Eternygen) focuses on research and development of innovative drugs for dietary-related metabolic diseases.The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transporter NaCT. It focuses research on NaCT, a regulator of lipid metabolism involved in the pathogenesis. Eternygen provides drugs for diseases such as fatty liver, diabetes mellitus and obesity. Its proprietary molecules work on glucose metabolism and hepatic lipid oxidation and acts as a therapeutic target by influencing the mammalian energy metabolism. The company works in collaboration with other contract research organizations for drug discovery and pre-clinical development in the field of metabolic diseases. Eternygen is headquartered in Berlin, Germany.
This comprehensive company report of Eternygen GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.